Gensco Leadership

Robert Wilbur, Pharm.D., CPh. | Executive Director, Medical Affairs

Robert received his Bachelors of Science degree from the University of South Florida, Doctorate of Pharmacy degree from Mercer University, and completed a Clinical Residency at Emory University.

Through his 27 years in the profession of pharmacy, Robert has been involved in almost every facet of the industry. He has served as the Chief Clinical Pharmacist for a large metropolitan hospital, conducted clinical drug trials, consulted for three international pharmaceutical companies, and was a Vice President for an international healthcare company.

Robert is now the Executive Director of Medical Affairs for Gensco Laboratories.

Return to Gensco Leadership Team Page »

Gensco Executive Team

Paul Zimmerman, M.D. | Chairman & CEO   bio »

Frank Aguilar | VP, National Accounts

Crystal Lore | VP, Business Development   bio »

Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs   bio »

David A. Andry | Senior Director National Accounts

Lewis Archibeck | Sr. Sales Executive

Lisa Capote, Esq | General Counsel

Return to Gensco Leadership Team Page »

GENSCO® TRENDING

Gensco Pharma® Acquires Global Rights and IP for RizaFilm® and RizaPort® May 13, 2025 Featured, Industry, Press Release, Product Update - Gensco Pharma acquires global rights to RizaFilm® and RizaPort®, with a U.S. migraine treatment launch planned for Q4 2025 and… more...

Looking To The Future

RizaFilm migraine treatment launching Q5

RizaFilm migraine treatment launching Q5

 

 

 

Launching in Q4 2025, RizaFilm® delivers fast, water-free migraine relief through novel oral dissolvable film (ODF) technology—offering unmatched convenience, portability, and speed in a tablet-dominated market.

See all news